Ruxolitinib for Acute Graft-versus-Host Disease
- PMID: 32726540
- DOI: 10.1056/NEJMc2020763
Ruxolitinib for Acute Graft-versus-Host Disease
Comment in
-
Ruxolitinib for Acute Graft-versus-Host Disease. Reply.N Engl J Med. 2020 Jul 30;383(5):10.1056/NEJMc2020763#sa3. doi: 10.1056/NEJMc2020763. N Engl J Med. 2020. PMID: 32726542 No abstract available.
Comment on
-
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.N Engl J Med. 2020 May 7;382(19):1800-1810. doi: 10.1056/NEJMoa1917635. Epub 2020 Apr 22. N Engl J Med. 2020. PMID: 32320566 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources